Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug
SUBSTITUTED BY A1428
Email me when S 9497 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 9497. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill forces health insurers and prescription‑drug providers in New York to cover a brand‑name version of a drug if the generic version listed on their formulary is unavailable because the FDA has identified a supply problem. Coverage must be at the same cost level as the generic until the shortage is fixed. This protects patients from interruptions in treatment.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 9497
3 free questions a day, no accountHearings
- Rules Committee MeetingRules · Jun 4, 2026
- Insurance Committee MeetingInsurance · Apr 20, 2026
History
- SUBSTITUTED BY A1428
- ORDERED TO THIRD READING CAL.1489
- COMMITTEE DISCHARGED AND COMMITTED TO RULES
- REPORTED AND COMMITTED TO FINANCE
- REFERRED TO INSURANCE
Sponsors
- Nathalia Fernandez (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 9497 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 9497 freeOr ask your AI assistant about S 9497 directly:
Add to Claude, ChatGPT or Cursor